TMO
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc historical holders
total: 22
Lone Pine Capital Thermo Fisher Scientific Inc transactions over time
- Total transactions:
- 7
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2022 Q1
- Held for:
- 4 quarters
- Latest activity:
- 2023 Q1
Stephen Mandel has been an institutional investor in Thermo Fisher Scientific Inc (TMO) since at least 2013 Q2. According to 2026 Q1 report, Stephen Mandel doesn't hold any shares. In our earliest available record from 2013 Q2, Lone Pine Capital held about 2.77M shares of TMO. Stephen Mandel later completely sold out the position and reinvested in TMO again in 2022 Q1. Since at least 2013 Q2, Lone Pine Capital has made 6 more transactions in this position.
When did Stephen Mandel exit their TMO position?
Stephen Mandel no longer holds Thermo Fisher Scientific Inc (TMO). They sold off their entire position in 2023 Q1, closing out an investment that began in 2013 Q2.
Has Stephen Mandel reinvested in TMO after selling?
Yes, Stephen Mandel has shown renewed interest in Thermo Fisher Scientific Inc (TMO). After completely selling their position, they reinitiated an investment in 2022 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $569.74
- Weighted AVG sell price:
- $548.50
TMO transactions history by Lone Pine Capital
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q1
|
0.00%
|
0
|
$550.69
|
|
-100% (-587,696)
|
-3.09%
|
|
2022 Q4
|
3.09%
|
587,696
|
$550.69
|
$323,638,310
|
-33.62% (-297,630)
|
-1.54%
|
|
2022 Q3
|
4.23%
|
885,326
|
$507.19
|
$449,028,000
|
-5.04% (-46,966)
|
-0.22%
|
|
2022 Q2
|
4.77%
|
932,292
|
$543.28
|
$506,496,000
|
+79.04% (+411,583)
|
+2.11%
|
|
2022 Q1
|
1.83%
|
520,709
|
$590.65
|
$307,557,000
|
new
|
+1.83%
|
|
2013 Q3
|
0.00%
|
$84.63
|
-100% (-2,766,476)
|
|||
|
2013 Q2
|
1.18%
|
$84.63
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.